Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program
Article excerpt
Highlighted: the sentence this signal was extracted from
SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, announced a new, independent cost savings model that examined the measurable clinical and economic value of Omada's GLP-1 program. 1 GlobalData, a data analytics and consulting company, recently published a report estimating greater disease reduction and higher cumulative cost savings with Omada's GLP-1 solutions compared to standard care. Using their peer-reviewed Markov microsimulation model approach, the model projects disease-onset trajectories and associated total healthcare savings using data from nationally representative datasets as well as clinical data from nearly 25,000 Omada GLP-1 Care Track members. 1 Findings from the simulation model offer a new criteria set for guiding GLP-1 strategy decisions, based on short and long-term value metrics, rather than upfront cost avoidance alone. The model projected cost savings and disease onset reduction over 5 years, taking into account actual persistence levels and clinical outcomes from members in Omada's GLP-1 solutions, including 12.4% average weight loss at twelve months. 1 "Obesity and its downstream conditions have cost employers more every year, 2 and we're reaching a point where employers and members are demanding a care model built for the long run," said Wei-Li Shao, President at...
Keep reading with a free account
The rest of this article, and every signal for Omada Health, is in your free account.